How DPC Could Be The Leaders in Neuropathy Treatment
You didn’t go into Direct Primary Care to rush through 30 patients a day. You did it to deliver better care—on your terms. But even the best DPC practices often have room for growth and expansion into new markets. What if you could create a new, meaningful revenue stream while solving one of the most common and frustrating patient issues: neuropathy?
Millions of Americans, over 20 million in fact suffer from peripheral neuropathy—burning, tingling, pain, and numbness caused by nerve damage. As a physician, you also understand how sick these people actually can be. You know yourself that the traditional medical system often fails them. Most are sent home with pain meds, with little hope for real relief.
The NeuropathyDR® Treatment Center model offers a different approach. It’s not a gadget, and it’s not a franchise. It’s a turnkey, licensable clinical system that gives DPC physicians everything they need to effectively treat many forms of neuropathy.
From exclusive clinical protocols and branded tools to marketing strategies and hands-on training, NeuropathyDR® equips physicians to make a real difference—while generating additional income. The treatment protocol is non-invasive, research-backed, and designed for implementation within your existing DPC model.
For many clinics, this has been a game-changer. Not only are patients seeing meaningful improvements, but physicians are reporting a strong, steady income from our home treatment systems and even more so in those clinics who provide our research backed care for these patients we can help train your staff to implement.
Your community is already looking for this care. You can be the one to provide it—without compromising your values or independence.
If you are seriously interested in learning more, let’s talk. Find a slot on my calendar at You didn’t go into Direct Primary Care to rush through 30 patients a day. You did it to deliver better care—on your terms. But even the best DPC practices often have room for growth and expansion into new markets. What if you could create a new, meaningful revenue stream while solving one of the most common and frustrating patient issues: neuropathy?
Millions of Americans, over 20 million in fact suffer from peripheral neuropathy—burning, tingling, pain, and numbness caused by nerve damage. As a physician, you also understand how sick these people actually can be. You know yourself that the traditional medical system often fails them. Most are sent home with pain meds, with little hope for real relief.
The NeuropathyDR® Treatment Center model offers a different approach. It’s not a gadget, and it’s not a franchise. It’s a turnkey, licensable clinical system that gives DPC physicians everything they need to effectively treat many forms of neuropathy.
From exclusive clinical protocols and branded tools to marketing strategies and hands-on training, NeuropathyDR® equips physicians to make a real difference—while generating additional income. The treatment protocol is non-invasive, research-backed, and designed for implementation within your existing DPC model.
For many clinics, this has been a game-changer. Not only are patients seeing meaningful improvements, but physicians are reporting a strong, steady income from our home treatment systems and even more so in those clinics who provide our research backed care for these patients we can help train your staff to implement.
Your community is already looking for this care. You can be the one to provide it—without compromising your values or independence.
If you are seriously interested in learning more, let’s talk. Find a slot on my calendar at NeuropathyDR.org
This is exactly what DPC should not be doing. Primary Care is already capable of identifying treatable forms of peripheral neuropathy and treating them. Finding new ways to make a hard to treat problem into a cashflow bonanza is something we should be steering our patients away from. Yes, patients are desperate, but we should not be increasing our income by mining that desperation.